Sustained haematological response to high-dose oral alfacalcidol in patients with myelodysplastic syndromes.
Kelsey
S M
SM
Newland
A C
AC
Cunningham
J
J
Makin
H L
HL
Coldwell
R D
RD
Mills
M J
MJ
Grant
I R
IR
D001769:Blood / Q000187:drug effects*; D005260:Female; D006801:Humans; D006887:Hydroxycholecalciferols / Q000008:administration & dosage*; D008297:Male; D009190:Myelodysplastic Syndromes / Q000188:drug therapy*
D006887:Hydroxycholecalciferols; C008088:alfacalcidol